Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 613 is a protein-coding gene product containing C2H2-type zinc finger motifs, which are known to enable direct DNA binding and function primarily in transcription regulation[4][3][1]. ZNF613 is predicted to act as a DNA-binding transcription factor and is likely located within the cell nucleus, where it may regulate transcription by RNA polymerase II[4]. Like other mammals’ zinc finger proteins, ZNF613 belongs to the largest transcription factor family and may participate in complex cellular processes such as gene expression, cell differentiation, and maintenance of genome stability[6][3][8]. However, its specific biological and pathological roles remain to be defined, and it is not currently recognized as a direct drug target or clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 613 (ZNF613).